IRVING, Texas, May 14, 2018 — GI pathologists at Inform Diagnostics, formerly Miraca
Life Sciences, continue to publish noteworthy articles in respected peer-reviewed
One recent article challenges current clinical assumptions about gastrointestinal
polyps. Published in
American Journal of Gastroenterology,
“Lesions of All Types Exist in Colon Polyps of All Sizes” reports the stratification of advanced neoplasia by polyp size. The authors
from Inform Diagnostics, gastrointestinal pathologists
Kevin Turner, DO, and
Robert M. Genta, MD, with their collaborator Amnon Sonnenberg, MD, MSc., reviewed histopathologic
records of 550,811 polyps from 483,998 unique patients who underwent colonoscopy
with polypectomy between January 2008 and December 2014. The article concludes
that “…one quarter of all advanced histopathology existed
in polyps of <10 mm.”
Another significant recent article provides further diagnostic criteria
for eosinophilia by quantifying the normal eosinophil content in the duodenum.
“Quantification of the duodenal eosinophil content in adults: a necessary
step for an evidence-based diagnosis of duodenal eosinophilia” was published in
Alimentary Pharmacology & Therapeutics by authors Genta, Turner, and Sonnenberg. Eosinophils were counted in
specimens from 370 adults. Additionally, patient records were extracted
from a database of 458,668 adult subjects. The article concludes that
“…a cut-off count of 20 eos/hpf would be useful to separate
patients with normal from those with elevated duodenal eosinophilic infiltrations.”
The above article follows up on previous research led by Dr. Genta that
establish criteria for the eosinophil content of the colon (The American Journal of Surgical Pathology, 2017) and for the eosinophil content of the stomach (Modern Pathology, 2011). Earlier, researchers at Inform Diagnostics published the landmark paper
on EoE: “Eosinophilic Esophagitis: A Prevalent Disease in the United
States That Affects All Age Groups,” (Gastroenterology, 2008).
These recent publications highlight the commitment to research and advancing
science among the gastrointestinal pathology faculty at Inform Diagnostics.
The organization’s high case volume has created a large database
that affords significant research opportunities. Additional
GI scientific publications by authors at Inform Diagnostics may be viewed online.
Overall, Inform Diagnostics pathologists have more than 2,500 career publications
and typically publish more than 35 research papers and book chapters each
year. Additionally, Inform Diagnostics pathologists are cited more than
three times the average for academic clinical medicine.
About Inform Diagnostics
Headquartered in Irving, Texas, Inform Diagnostics is the largest independent
anatomic pathology provider in the United States. The organization was
founded in 1996 and previously known as Miraca Life Sciences since 2012.
Inform Diagnostics’ premier medical laboratories focus on GI pathology,
dermatopathology, hematopathology, urologic pathology, and breast pathology.
Each Inform Diagnostics pathologist is a fellowship-trained subspecialist.
Learn more online about Inform Diagnostics’
extraordinary quality and service.
# # #